Please Note! This particular section of Mapleleafweb is outdated and is in the process of being updated and migrated to the new version of Maple Leaf Web. Maple Leaf Web makes no guarantee that the information below is up to date and or correct.

Please update your bookmarks and thank you for your patience. Please contact us if you have any questions or comments

Site Map | Contact | Help 

Mapleleafweb.com Logo  
  in-curve
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
Feature:
spacer
spacer

Jump to . . .
» Introduction
» Ethical Issues?
» Politics of Cloning
» Bill C-56 and Bill C-13
» Current AHR Regulation
» Summary of Bill C-13
» Reaction to Bill C-13
» The Future of Bill C-13
 
More Information
« More Web Features
« Current Event Spotlight
 
External Info & Links
« Bill C-13: Full Text
« Bill C-47: Full Text
« CIHR Website
« Health Canada
 

How are AHR Technologies Currently Regulated?
Canadian Institutes of Health Research Guidelines

Currently, Canada has no federal legislation governing assisted human reproduction and genetic research using human reproductive materials. Scientists and researchers seeking federal funding follow guidelines set by the Canadian Institutes of Health Research (CIHR); a parliamentary body created in 2000 that is Canada’s primary federal funding agency for medical research. In 2002, the Canadian Institutes of Health Research (CIHR) issued a revised set of guidelines:

  • Scientists cannot create embryos solely for research purposes, either to create stem cell lines or to perform other research
  • They can perform research on surplus human embryos produced for infertility treatments that are up to fourteen days old. (Since 1987, infertility clinics have routinely been performing research on excess embryos in order to improve success rates.)
  • Stem cells can be created using surplus human embryos left over from infertility treatments that are up to fourteen days old (this has only been permitted since 2002).
  • Researchers must have free and informed consent from donors before using adult stem cells for research. This consent must be renewed at the time that the actual research takes place, to give donors a chance to change their minds
  • Researchers cannot use eggs, sperm, or embryos obtained through a commercial transaction.
  • Research on stem cell lines obtained from outside of Canada is only permitted if the stem cells were created following CIHR guidelines
  • It is not permitted to combine non-human stem cells with a human embryo or fetus

Despite the guidelines, groups argue that Canada needs comprehensive human reproductive legislation for several reasons:

  • Guidelines are tied to receiving federal funding, which means there are no legal implications for not following them. Theoretically, scientists who don’t require funding could ignore the guidelines.
  • The guidelines have little impact on the commercialization of sperm and eggs. Currently, privately run infertility clinics in Canada routinely pay men $70 for sperm donations, while women can earn up to $2,000 for egg donations. Furthermore, childless couples may pay a surrogate up to $15,000 to carry a baby to term.
  • The guidelines can be revised at any time without being debated in Parliament. For example, the revised guidelines end a voluntary moratorium by the scientific community on embryonic stem cell research. While the government supports the limited stem cell research proposed in the guidelines, it could be extended at any time without parliamentary approval.
  • Lack of parliamentary debate means the public is often not aware of the issues. The fact that fertility clinics have been performing research on surplus human embryos since 1987 only came to light in the recent debates over Bill C-13.

Next Page >>
Summary of Bill C-13


 

© 2001-2006 Maple Leaf Web.
All Rights Reserved


This page was last modified: August 10, 2007